Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Insulin pump during labor: a pilot study to see if It's safe and practical

NCT ID NCT07420972

First seen Feb 20, 2026 · Last updated Jun 19, 2026 · Updated 22 times

Summary

This pilot study will test whether it is safe and practical for pregnant women with type 1 or type 2 diabetes to continue using their insulin pump during labor, instead of switching to IV insulin. About 30 women who already use an insulin pump will be allowed to keep using it during labor, following a hospital safety plan. Their outcomes will be compared to similar patients from the past who used IV insulin. The goal is to gather information to plan a larger future study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

insulin pump (hybrid closed loop automated insulin delivery system)

What this could lead to

If successful, this could support a larger study to offer pregnant women with diabetes the option to continue using their insulin pump during labor, potentially reducing stress and improving blood sugar control.

What could go wrong

This is a very small pilot study (30 people) not designed to prove one method is better. It may not show clear benefits, and safety concerns could still require switching to IV insulin.

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.